-
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A
Speaker(s): Dr. Jonathan Roberts
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest in research, breakthrough developments, and more.